Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

(2011) Ralph A. DeFronzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Insulin Resistance Predicts Rapid Virologic Response to Peginterferon/Ribavirin Combination Therapy in Hepatitis C Genotype 4 Patients

(2010) Mahmoud Khattab et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Macrophages, Inflammation, and Insulin Resistance

(2010) Jerrold M. Olefsky et al.   Annual Review of Physiology

Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus

(2010) Sandra Ciesek et al.   GASTROENTEROLOGY

Changes in Insulin Sensitivity and Body Weight During and After Peginterferon and Ribavirin Therapy for Hepatitis C

(2010) Hari S. Conjeevaram et al.   GASTROENTEROLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired β-Cell Function

(2010) Silke A. Herzberg-Schäfer et al.   PLoS One

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

(2010) Kenneth F. Schulz et al.   PLOS MEDICINE

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

(2009) Manuel Romero-Gómez et al.   HEPATOLOGY

Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?

(2009) Lawrence Serfaty et al.   JOURNAL OF HEPATOLOGY

Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

(2009) Mahmoud Khattab et al.   LIVER INTERNATIONAL

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis

(2009) John T. Pesce et al.   PLoS Pathogens

Insulin resistance in chronic hepatitis C, genotypes 1 and 4: The unfortunate reality

(2008) Dawn M. Torres et al.   HEPATOLOGY

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin

(2008) Kathrin Overbeck et al.   JOURNAL OF HEPATOLOGY

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

(2008) Donna L. White et al.   JOURNAL OF HEPATOLOGY

Interferon-based therapy for chronic hepatitis C: current and future perspectives

(2008) Stefan Zeuzem   Nature clinical practice. Gastroenterology & hepatology

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY